DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

Without diabetes · 24 weeks · n=338

Randomised, double-blind, placebo-controlled. Efficacy estimand.

Mean body weight change at 24 weeks
  • Retatrutide 1 mg−7.2%
  • Retatrutide 4 mg (pooled)−12.9%
  • Retatrutide 8 mg (pooled)−17.3%
  • Retatrutide 12 mg−17.5%
  • Placebo−1.6%
Published paper PubMed abstract NCT04881760

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.